The evolving history of influenza viruses and influenza vaccines.
about
New Insights into the Generation of CD4 Memory May Shape Future Vaccine Strategies for InfluenzaB Cells and Functional Antibody Responses to Combat InfluenzaMatrix-M Adjuvated Seasonal Virosomal Influenza Vaccine Induces Partial Protection in Mice and Ferrets against Avian H5 and H7 ChallengeSynthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responsesSurveillance systems and methods for monitoring the post-marketing safety of influenza vaccines at the Centers for Disease Control and Prevention.Protection against H5N1 Influenza Virus Induced by Matrix-M Adjuvanted Seasonal Virosomal Vaccine in Mice Requires Both Antibodies and T Cells.A Novel Endonuclease Inhibitor Exhibits Broad-Spectrum Anti-Influenza Virus Activity In VitroReversion of Cold-Adapted Live Attenuated Influenza Vaccine into a Pathogenic VirusEvaluation of multivalent H2 influenza pandemic vaccines in mice.Surveillance Study of Influenza Occurrence and Immunity in a Wisconsin Cohort During the 2009 PandemicAvailable influenza vaccines: immunization strategies, history and new tools for fighting the disease.Influenza vaccines: challenges and solutions.Ten influenza seasons in France: distribution and timing of influenza A and B circulation, 2003-2013Development of a heat-stable and orally delivered recombinant M2e-expressing B. subtilis spore-based influenza vaccine.Retrospective public health impact of a quadrivalent influenza vaccine in the United States.Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as AdjuvantTechnical guidelines for the application of seasonal influenza vaccine in China (2014-2015).Role of vaccination in the sustainability of healthcare systems.Quadrivalent influenza vaccine: a new opportunity to reduce the influenza burden.Influenza vaccines: unmet needs and recent developments.Epidemiology of influenza B in Australia: 2001-2014 influenza seasons.Influenza vaccine effectiveness: best practice and current limitations of the screening method and their implications for the clinic.Effectiveness of Influenza Vaccination for Individuals with Chronic Obstructive Pulmonary Disease (COPD) in Low- and Middle-Income Countries.The PA Endonuclease Inhibitor RO-7 Protects Mice from Lethal Challenge with Influenza A or B Viruses.A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control.Cost-effectiveness of inactivated seasonal influenza vaccination in a cohort of Thai children ≤60 months of age.Evolution of Influenza A Virus by Mutation and Re-Assortment.Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.Evolution and Vaccination of Influenza Virus.Modeling Influenza Antigenic Shift and Drift with LEGO Bricks.Immunogenicity and safety of a split-virion quadrivalent influenza vaccine in adults 18-60 years of age in the Republic of Korea.Influenza vaccines: Evaluation of the safety profile.Immunogenicity and Safety of the New Inactivated Quadrivalent Influenza Vaccine Vaxigrip Tetra: Preliminary Results in Children ≥6 Months and Older Adults.The Respiratory Environment Diverts the Development of Antiviral Memory CD8 T Cells.A trivalent, inactivated influenza vaccine (Vaxigrip®): summary of almost 50 years of experience and more than 1.8 billion doses distributed in over 120 countries.The Future of Influenza Vaccines: A Historical and Clinical PerspectiveHormonal Regulation of Physiology, Innate Immunity and Antibody Response to H1N1 Influenza Virus Infection During Pregnancy
P2860
Q26752546-4C5F1B1C-3EEA-4514-A6BA-280B808BB377Q26801639-F2210838-FF24-483A-8F39-713CC9C78A43Q27300233-3D0ECE29-5E00-4892-A5CF-D4B223ED0A9CQ30205195-EDFD0EE6-ECED-41D4-8B26-190CC5208D13Q30249793-A795FC0A-D3B6-4BAB-AAD4-CB54B93F7794Q30382787-6C21184F-48CC-45B8-B38C-4DA000476076Q30390167-1DF1B510-0518-452C-B18F-777E183FDB0EQ30390811-FDB032AA-B0B1-4BD5-BD4A-52AE217385C1Q30398507-3970E607-3DA2-4CCB-BBE2-8B98F5AD54C3Q33904286-F701752F-A026-413D-9798-32AC06BA4B5FQ34532079-231201B5-11F7-4FEC-86E3-66FF5B83E34BQ35184572-D87D34C0-AB33-453E-9DBD-D007B2452049Q35750762-6EC82EC7-3FC9-483B-AFDB-67A2DE1F3BCAQ35886473-52EB5DCD-E1DD-478D-A2D3-92AF28901590Q35995259-DB858CA4-9859-4CCD-90F7-826E8C4A0F37Q36086281-9B5EC442-FADA-4256-B1F2-3A98E710953CQ36256314-D1E2218E-6D2C-4ECE-878B-68F7BFC4101AQ36714717-42C11EF7-18AF-403C-9123-60488BC4814FQ37011571-FA947049-9328-45B5-92AE-B455AF527626Q37518273-B4702681-185D-4D19-8312-16C2E9D041F1Q37638402-13A436A8-8B69-48A3-A006-47D7B56D0F07Q38221641-E5A58135-0EBF-476F-A035-51DFA97BCC67Q38595246-6F405A2B-55BA-49CB-9F9D-678119C2661CQ38963385-C931E874-2B01-44A8-81DD-552572EAA661Q39322780-90C8DFEA-7A93-4D1F-B149-4E4707E8898AQ40072175-F106984E-F948-4B3B-A62F-8A7EA4BCB60EQ40092344-E45C7A1D-692F-4ED5-9EFB-C26C4FBA0846Q40116011-9BA806AE-BC37-4757-9062-F760F8C33034Q40131949-79899083-3885-4A8D-B4F6-601721276C00Q41072364-D46631A6-2FCD-4EA4-A08F-C1F9D293C0AFQ41995736-5F283CDC-E4A8-4409-838D-61D054CAF654Q49345779-A2569533-FCAE-431F-A34E-43745D9285C5Q50420352-64D8CC85-30AA-43E4-B944-C39A2CB37499Q53280520-E17677DB-DE6B-488E-A026-A626834743D5Q54626497-1C52A2C7-D1D1-45FD-82F9-61277BFAE376Q57166818-DD8815A2-9A91-4EF9-AF19-A5A6134A067DQ58699144-E9FE2167-641F-41AE-9FE9-10616EE2EEFE
P2860
The evolving history of influenza viruses and influenza vaccines.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The evolving history of influenza viruses and influenza vaccines.
@en
type
label
The evolving history of influenza viruses and influenza vaccines.
@en
prefLabel
The evolving history of influenza viruses and influenza vaccines.
@en
P2860
P1476
The evolving history of influenza viruses and influenza vaccines.
@en
P2093
Claude Hannoun
P2860
P304
P356
10.1586/14760584.2013.824709
P577
2013-09-12T00:00:00Z